Table 2. Correlates of demographic characteristics, STI symptoms and pathogens among male patients with N. meningitidis US NmNG urethritis and controls, Vietnam*.
| Variables | Cases, n = 19 | Controls, n = 76 | Univariable analysis† |
Multivariable analysis† |
|||
|---|---|---|---|---|---|---|---|
| OR (95% CI) | p value | aOR (95% CI) | p value | ||||
| Mean age, y | 26.9 | 27.8 | 0.90 (0.75–1.07) | 0.232 | NA | ||
| Mean years of education | 10.8 | 11.0 | 0.96 (0.75–1.23) | 0.760 | NA | ||
| Medical examination >3 d after symptom onset |
13 (68.4) |
11 (14.5) |
18.41 (4.04–83.86) |
<0.001 |
|
16.00 (2.00–127.54) |
0.009 |
| Symptoms | |||||||
| Pyuria | 2 (10.5) | 10 (13.2) | 0.79 (0.16–3.79) | 0.764 | NA | ||
| Dysuria | 13 (68.4) | 65 (85.5) | 0.39 (0.12–1.19) | 0.098 | NA | ||
| Burning sensation during urination | 2 (10.5) | 57 (75.0) | 0.05 (0.01–0.22) | <0.001 | 0.08 (0.01–0.46) | 0.005 | |
| Discharge |
4 (21.1) |
16 (21.1) |
1.00 (0.26–3.89) |
>0.999 |
|
|
|
| Time between symptom onset and medical consultation, d | |||||||
| Mean | 4.7 | 3.0 | 1.92 (1.18–3.13) | 0.009 | NA | ||
| Median (range) |
5 (3–12) |
3 (1–14) |
|
|
|
|
|
| History of meningococcal vaccine | |||||||
| Ever | 0 | 1 (1.3) | NA | ||||
| Never | 12 (63.2) | 51 (67.1) | NA | ||||
| Do not know, do not remember |
7 (36.8) |
24 (31.6) |
NA |
|
|
|
|
| Positive tests | |||||||
| HIV | 2 (10.5) | 6 (7.9) | 1.36 (0.26–7.20) | 0.716 | NA | ||
| Syphilis | 2 (10.5) | 3 (3.9) | 2.67 (0.45–15.96) | 0.283 | NA | ||
| Gonorrhea | 0 (0.0) | 75 (98.7) | NA | NA | |||
| Chlamydia | 4 (21.1) | 7 (9.2) | 2.57 (0.67–9.83) | 0.168 | 3.83 (0.37–39.43) | 0.258 | |
| Ureaplasma | 1 (5.3) | 8 (10.5) | 0.48 (0.06–4.01) | 0.502 | NA | ||
| Mycoplasma | 1 (5.3) | 10 (13.2) | 0.39 (0.04–3.10) | 0.372 | NA | ||
*Values are no. (%) except as indicated. aOR, adjusted odds ratio; NA, not applicable; OR, odds ratio. †Conditional logistic regression.